AGF Management’s Royalty Pharma RPRX Stock Holding History

AGF Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.15M	Sell	56,268 -25,203	-31%	-$1.31M	0.01%	359
2026 Q1	$3.91M	Buy	81,471 +4,365	+6%	+$191K	0.02%	304
2025 Q4	$2.98M	Sell	77,106 -14,156	-16%	-$540K	0.01%	388
2025 Q3	$3.22M	Sell	91,262 -1,950	-2%	-$70.6K	0.01%	390
2025 Q2	$3.36M	Buy	93,212 +12,732	+16%	+$422K	0.02%	307
2025 Q1	$2.51M	Sell	80,480 -18,032	-18%	-$572K	0.01%	420
2024 Q4	$2.51M	Buy	+98,512	New	+$2.61M	0.01%	396
2024 Q2	–	Sell	-16,657	Closed	-$506K	–	749
2024 Q1	$506K	Buy	+16,657	New	+$491K	﹤0.01%	629
2023 Q2	–	Sell	-93,508	Closed	-$3.37M	–	745
2023 Q1	$3.37M	Buy	93,508 +14,088	+18%	+$522K	0.02%	377
2022 Q4	$3.14M	Buy	+79,420	New	+$3.31M	0.02%	438

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AGF Management's RPRX Position: Q2 2026 in Review

AGF Management reduced its Royalty Pharma (RPRX) stake by 31% in Q2 2026, selling an estimated $1.31M and leaving 56,268 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #359.

AGF Management first reported a position in RPRX in Q4 2022 and has held it in 10 quarters since. The position peaked at $3.91M in Q1 2026. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

AGF Management held 56,268 shares of Royalty Pharma worth $3.15M as of Q2 2026.
AGF Management sold 25,203 Royalty Pharma shares in Q2 2026, an estimated $1.31M.
Royalty Pharma made up 0.01% of AGF Management's portfolio in Q2 2026, its #359 holding.
AGF Management first reported a position in Royalty Pharma in Q4 2022 and has held it in 10 quarters since.
AGF Management's Royalty Pharma position peaked at $3.91M in Q1 2026.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.